Authors:
Christopher Jenkins, PhD, MPH, RBP, CHMM,
Senior Vice President of Biosafety and Gene Therapy,
WCG Biosafety, a Division of the WIRB-Copernicus Group

Currien McDonald, MD, CIP
IRB Chair,
Western Institutional Review Board, a WIRB-Copernicus Group Company

Print Friendly